Filing Details

Accession Number:
0001610717-24-000546
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-12-18 16:08:51
Reporting Period:
2024-12-16
Accepted Time:
2024-12-18 16:08:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1628171 Revolution Medicines Inc. RVMD () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1246842 A Mark Goldsmith C/O Revolution Medicines, Inc.
700 Saginaw Drive
Redwood City CA 94063
See Remarks No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-12-16 11,714 $45.40 325,056 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 20,424 Indirect Trust
Common Stock 20,424 Indirect Trust
Common Stock 465,604 Indirect Trust
Footnotes
  1. Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after July 15, 2023.
  2. Includes 167,125 RSUs.
  3. Held by Jonathan Goldsmith Revocable Trust.
  4. Held by Rebecca Eve Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.
  5. Held by Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust.